Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
intrauterine device
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:assemblyLocation |
office-based procedure
|
| gptkbp:availability |
prescription only
|
| gptkbp:brand |
gptkb:Kyleena
|
| gptkbp:clinicalTrials |
WHO guidelines
NICE guidelines studies on safety studies on effectiveness ACOG recommendations studies on long-term use studies on side effects studies on user satisfaction |
| gptkbp:competesWith |
gptkb:Liletta
gptkb:Mirena Skyla |
| gptkbp:contraindication |
liver disease
pregnancy breast cancer active pelvic infection uterine abnormalities |
| gptkbp:decommissioningDate |
office-based procedure
|
| gptkbp:duration |
5 years
|
| gptkbp:effectiveDate |
99%
|
| gptkbp:healthcare |
positive user reviews
high satisfaction rates discuss risks and benefits know when to seek help low discontinuation rates monitor for side effects understand insertion process |
| https://www.w3.org/2000/01/rdf-schema#label |
Kyleena
|
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:marketedAs |
long-acting reversible contraception
hormonal IUD |
| gptkbp:offers |
varies by insurance
|
| gptkbp:primaryMission |
birth control
|
| gptkbp:regulatoryCompliance |
CE mark
TGA_approval Health_Canada_approval |
| gptkbp:releaseDate |
2016
|
| gptkbp:route |
intrauterine
|
| gptkbp:runnerUp |
annual check-up
|
| gptkbp:sideEffect |
headaches
breast tenderness acne cramps irregular bleeding |
| gptkbp:triggerType |
thickens cervical mucus
thins uterine lining inhibits sperm movement |
| gptkbp:type |
Levonorgestrel
|
| gptkbp:userDemographics |
women of reproductive age
women seeking long-term contraception women who prefer non-daily contraception women with heavy menstrual bleeding |